Insider · CIK 0001409232

Kidron Miriam

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001409232

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-24	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+208K sh	—	—	1,341,263
2026-09-24	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+209K sh	—	—	1,550,554
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−104K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−100K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−70K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−47K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−100K sh	—	—	0
2026-09-24	ORMPORAMED PHARMACEUTICALS INC. · Stock option (right to buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−72K sh	—	—	0
2026-03-30	ORMPORAMED PHARMACEUTICALS INC.F Tax Payment	Director, Chief Scientific Officer	FTax Payment	−435K sh	$3.31	−$1.44M	1,133,138
2026-03-25	LFWDLifeward Ltd.A Award	Director	AAward	+7,657 sh	—	—	7,657
2026-03-17	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+120K sh	—	—	1,568,222
2026-01-22	ORMPORAMED PHARMACEUTICALS INC.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+19K sh	—	—	1,448,664
2026-01-22	ORMPORAMED PHARMACEUTICALS INC. · Performance Stock UnitsM Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	−19K sh	—	—	0
2026-01-14	ORMPORAMED PHARMACEUTICALS INC.G Gift	Director, Chief Scientific Officer	GGift	−86.2K sh	—	—	1,343,498
2025-12-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+121K sh	—	—	1,314,664
2025-12-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+115K sh	—	—	1,429,664
2025-12-31	ORMPORAMED PHARMACEUTICALS INC. · Performance Stock UnitsA Award	Director, Chief Scientific Officer	AAward	+19K sh	—	—	19,000
2025-02-11	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+74K sh	—	—	1,074,666
2025-02-11	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+52K sh	—	—	1,126,666
2025-02-11	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+66.7K sh	—	—	1,193,333
2025-01-02	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+207K sh	—	—	1,000,666
2024-11-07	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+30K sh	—	—	793,666
2024-01-04	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+296K sh	—	—	763,666
2023-05-26	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+53.5K sh	—	—	468,166
2023-04-17	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+213K sh	—	—	414,666
2023-03-14	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−100K sh	$2.01	−$201K	201,666
2022-07-28	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+34K sh	—	—	217,666
2022-07-28	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+84K sh	—	—	301,666
2022-01-03	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+42K sh	—	—	183,666
2022-01-03	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, Chief Scientific Officer	AAward	+72K sh	—	—	72,000
2021-08-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+66.7K sh	—	—	141,666
2021-02-03	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, Chief Scientific Officer	AAward	+100K sh	—	—	100,000
2020-01-08	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, Chief Scientific Officer	AAward	+100K sh	—	—	100,000
2019-09-12	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, Chief Scientific Officer	AAward	+104K sh	—	—	104,000
2019-02-26	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)D Disposition to Issuer	Director, Chief Scientific Officer	DDisposition to Issuer	−104K sh	—	—	0
2019-02-26	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, Chief Scientific Officer	AAward	+104K sh	—	—	104,000
2018-01-31	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, Chief Scientific Officer	AAward	+47K sh	—	—	47,000
2017-08-02	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−89.6K sh	$8.50	−$762K	75,000
2017-06-30	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+75K sh	—	—	164,636
2017-06-30	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Director, Chief Scientific Officer	AAward	+70K sh	—	—	69,999
2017-04-19	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−52.8K sh	$6.33	−$334K	89,636
2015-12-30	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−24K sh	$8.61	−$207K	142,450
2015-12-29	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−15K sh	$9.08	−$136K	166,450
2015-12-28	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−11K sh	$9.27	−$102K	181,450
2015-02-23	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+79.8K sh	—	—	192,450
2014-11-13	ORMPORAMED PHARMACEUTICALS INC.A Award	Director, Chief Scientific Officer	AAward	+9,788 sh	—	—	112,602
2014-09-11	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−8,699 sh	$8.44	−$73.4K	102,814
2014-09-10	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−23K sh	$8.40	−$193K	111,513
2014-09-04	ORMPORAMED PHARMACEUTICALS INC.S Sale	Director, Chief Scientific Officer	SSale	−8,301 sh	$9.41	−$78.1K	134,513
2014-08-01	ORMPORAMED PHARMACEUTICALS INC.M Exercise/Conversion	Director, Chief Scientific Officer	MExercise/Conversion	+143K sh	$0.01	+$1,713.768	142,814

Recent filings

Accepted (ET)
Sep 254
Kidron Miriam0001213900-26-103536
SEC(opens sec.gov)
Mar 314
Kidron Miriam0001213900-26-037446
SEC(opens sec.gov)
Mar 274
Kidron Miriam0001178913-26-001812
SEC(opens sec.gov)
Mar 184
Kidron Miriam0001213900-26-031015
SEC(opens sec.gov)
Jan 294
Kidron Miriam0001213900-26-009478
SEC(opens sec.gov)
Jan 214
Kidron Miriam0001213900-26-006215
SEC(opens sec.gov)
Jan 54
Kidron Miriam0001213900-26-001279
SEC(opens sec.gov)
Feb 114
Kidron Miriam0001213900-25-012241
SEC(opens sec.gov)

Companies

Address

1185 AVENUE OF THE AMERICAS THIRD FLOOR

NEW YORK, NY, 10036